Based on the provided abstracts, there is insufficient information to accurately summarize the function of the FGR gene (FGR proto-oncogene, Src family tyrosine kinase). The abstracts provided discuss fetal growth restriction (FGR) as a clinical condition and various molecular mechanisms involved in placental dysfunction, but they do not contain specific information about the FGR gene itself or its protein product. The abstracts focus on placental pathology, trophoblast function, and various signaling pathways involved in pregnancy complications, but none directly characterize the FGR proto-oncogene or its role as a Src family tyrosine kinase. To provide an accurate gene function summary, abstracts specifically addressing the FGR gene's molecular function, protein interactions, cellular localization, and biological roles would be required. The current literature provided discusses clinical FGR (the condition) rather than the FGR gene, making it impossible to ground any functional claims about this specific gene in the available evidence.